Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer

Abdul Majeeda Integrative Omics and Molecular Modeling Laboratory, Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan

Muhammad Tahir ul Qamara Integrative Omics and Molecular Modeling Laboratory, Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, PakistanCorrespondence[email protected]

Arooma Maryamb Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester, MA, USA

Muhammad Usman Mirzac Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, Canada

Laila Alhussaind Department of Biology, College of Science, Qassim University, Buraydah, Saudi Arabia

Seham Obaid Al Otaibie Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia

Ahmad Almatroudie Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia

Khaled S. Allemaileme Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia

Faris Alrumaihie Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia

Abdulaziz A. Aloliqif Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia

Faez Falah Alshehrig Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Aldawadmi, Saudi ArabiaCorrespondence[email protected]

show all

Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date